Lung cancer cases in older Asian adults more than tripled since 1990, GBD analysis finds

The number of tracheal, bronchus and lung (TBL) cancers diagnosed each year in older adults across Asia has risen steeply over three decades, and population ageing is set to keep the absolute burden high well past mid-century even as the underlying rates fall. That is the picture from a Global Burden of Disease 2023 analysis published in Annals of Medicine on 11 September 2026, which quantified the burden of TBL cancer among Asian adults aged 60 years and older from 1990 to 2023 [s1].

Over that period, incident cases rose from 334,563 to 1,102,794, and disability-adjusted life years (DALYs) — a combined measure of years lost to early death and to living with illness — climbed from 7.3 million to 19.4 million [s1]. Those are more-than-threefold increases in the raw counts. But the study's more careful message is that the counts and the rates tell different stories.

Rising cases, flat rates

Age-standardised rates, which strip out the effect of a population getting older and larger, "changed modestly," and the Asia-wide estimated annual percentage changes were "not statistically distinguishable from zero" [s1]. In plain terms: an average older Asian adult in 2023 was at roughly the same standardised risk as in 1990, but there are far more older Asian adults than there used to be, so the number of cancers has multiplied even without a rise in per-person risk.

The burden was not spread evenly. It increased sharply with age and remained consistently higher in males across the period [s1]. The authors also report that socioeconomic inequality in the burden "attenuated, particularly for mortality and DALYs" — the gap between richer and poorer settings narrowed over time, though the study does not claim it closed [s1].

What is actually driving the numbers

A demographic decomposition — a technique that separates how much of a change comes from population growth, from ageing, and from shifts in disease rates — attributed much of the absolute increase to population growth, while "negative age-specific-rate components partly offset demographic effects in several Central Asian countries" [s1]. That offset is the quiet good news buried in the figures: in parts of the region, the rate of disease per person has been edging down, cushioning what would otherwise be an even larger rise.

Lung cancer's dominant modifiable cause is tobacco, and the global scale of that risk factor frames why the trajectory matters. WHO's tobacco fact sheet states that tobacco kills more than 7 million people each year, including over 1.6 million non-smokers exposed to second-hand smoke, and that around 80% of the world's 1.2 billion tobacco users live in low- and middle-income countries [s2]. The study itself does not attribute its cases to specific exposures — it is a burden analysis, not an aetiological one — so the tobacco link is context rather than a finding of this paper.

The projection, and its limits

Using Bayesian age-period-cohort modelling, the authors projected the burden forward to 2050 [s1]. From 2024 to 2050, the age-standardised incidence rate and age-standardised DALY rate were projected to decline by 44.2% and 45.6% respectively — but "with only modest reductions in absolute numbers" [s1]. The two halves of that sentence are the whole story: per-person risk is expected to fall substantially, yet the sheer growth in the older population means the number of people diagnosed and dying stays stubbornly high.

Projections of this kind carry real uncertainty. Age-period-cohort models extrapolate from past trends and assume the structural forces behind them persist; a faster decline in smoking, a change in screening or treatment access, or a shift in air-pollution exposure could move the curve in either direction. The modelled 2050 figures should be read as a scenario consistent with recent history, not a forecast that fixes the future. The study also confines itself to adults aged 60 and over, so it says nothing about how the disease is shifting in younger Asian adults, where smoking initiation and cessation patterns differ and where any change would take decades to show up in the over-60 counts.

Why it matters for health systems

The practical implication the authors draw is about capacity, not risk. Population ageing "will sustain substantial burden," they conclude, "underscoring the need for targeted prevention and age-responsive health-system planning" [s1]. A region whose lung-cancer rates are falling can still face rising demand for diagnosis, surgery, radiotherapy and palliative care simply because there are more older people in whom the disease occurs — a mismatch that plans built on rates alone would miss. The finding sits alongside a wider run of evidence on the region's shift toward non-communicable disease as its populations age.

This article is informational and is not medical advice.

Sources

• The shifting burden of tracheal, bronchus and lung cancer in ageing Asia: structural drivers and projections to 2050 — Annals of Medicine (Zhu and colleagues), 11 September 2026
• Tobacco (fact sheet) — World Health Organization